Envestnet Portfolio Solutions’s Teva Pharmaceuticals TEVA Stock Holding History

Envestnet Portfolio Solutions’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Buy	7,311 +483	+7%	+$16.1K	﹤0.01%	1278
2026 Q1	$206K	Sell	6,828 -178	-3%	-$5.73K	﹤0.01%	1269
2025 Q4	$219K	Buy	+7,006	New	+$173K	﹤0.01%	1425
2025 Q2	–	Sell	-10,007	Closed	-$154K	–	1639
2025 Q1	$154K	Sell	10,007 -461	-4%	-$8.23K	﹤0.01%	1520
2024 Q4	$231K	Sell	10,468 -2,635	-20%	-$47.9K	﹤0.01%	1623
2024 Q3	$236K	Buy	13,103 +1,542	+13%	+$27K	﹤0.01%	1558
2024 Q2	$188K	Buy	+11,561	New	+$178K	﹤0.01%	1595

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Envestnet Portfolio Solutions's TEVA Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Teva Pharmaceuticals (TEVA) stake by 7.1% in Q2 2026, buying an estimated $16.1K and bringing the position to 7,311 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1278.

Envestnet Portfolio Solutions first reported a position in TEVA in Q2 2024 and has held it in 7 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Envestnet Portfolio Solutions held 7,311 shares of Teva Pharmaceuticals worth $248K as of Q2 2026.
Envestnet Portfolio Solutions bought 483 Teva Pharmaceuticals shares in Q2 2026, an estimated $16.1K.
Teva Pharmaceuticals made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #1278 holding.
Envestnet Portfolio Solutions first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.